Philadelphia-negative acute lymphoblastic leukemia developing in a CML patient in imatinib mesylate-induced complete cytogenetic remission

被引：11

作者：

Cherrier-De Wilde, S ^{[1
]}

Rack, K

Vannuffel, P

Delannoy, A

Hagemeijer, A

机构：

[1] Hop Jolimont, Hematol Unit, Haine Saint Paul, Belgium

[2] Inst Pathol & Genet, Loverval, Belgium

[3] Katholieke Univ Leuven, Dept Human Genet, Louvain, Belgium

来源：

LEUKEMIA | 2003年 / 17卷 / 10期

关键词：

D O I：

10.1038/sj.leu.2403094

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2046 / 2048

页数：3

共 12 条

[1] Clonal Ph-negative hematopoiesis in CML after therapy with imatinib mesylate is frequently characterized by trisomy 8
Andersen, MK
Pedersen-Bjorgaard, J
Kjeldsen, L
Dufva, IH
Brondum-Nielsen, K
[J]. LEUKEMIA, 2002, 16 (07) : 1390 - 1393
[2] Bose S, 1997, ACTA HAEMATOL-BASEL, V98, P155
[3] Fatal myelodysplastic syndrome developing during therapy with imatinib mesylate and characterised by the emergence of complex Philadelphia negative clones
Chee, YL
Vickers, MA
Stevenson, D
Holyoake, TL
Culligan, J
[J]. LEUKEMIA, 2003, 17 (03) : 634 - 635
[4] Dawson L, 1999, BRIT J HAEMATOL, V106, P104
[5] Mechanisms of disease - The biology of chronic myeloid leukemia
Faderl, S
Talpaz, M
Estrov, Z
O'Brien, S
Kurzrock, R
Kantarjian, HM
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (03) : 164 - 172
[6] Coexistence of independent myelodysplastic and Philadelphia chromosome positive clones in a patient treated with hydroxyurea
Flamm, MJ
Murty, VVVS
Rao, PH
Nichols, GL
[J]. LEUKEMIA RESEARCH, 2002, 26 (04) : 417 - 420
[7] Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia.
Kantarjian, H
Sawyers, C
Hochhaus, A
Guilhot, F
Schiffer, C
Gambacorti-Passerini, C
Niederwieser, D
Resta, D
Capdeville, R
Zoellner, U
Talpaz, M
Druker, B
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (09) : 645 - 652
[8] LIVAK KJ, 1995, PCR METH APPL, V4, P357
[9] Clonally unrelated BCR-ABL-negative acute myeloblastic leukemia masquerading as blast crisis after busulphan and interferon therapy for BCR-ABL-positive chronic myeloid leukemia
Manley, R
Cochrane, J
McDonald, M
Rigby, S
Moore, A
Kirk, A
Clarke, S
Crossen, PE
Morris, CM
Patton, WN
[J]. LEUKEMIA, 1999, 13 (01) : 126 - 129
[10] Sustained, clonal karyotype abnormalities in the Philadelphia chromosome negative cells of CML patients successfully treated with imatinib
Meeus, P
Demuynck, H
Martiat, P
Michaux, L
Wouters, E
Hagemeijer, A
[J]. LEUKEMIA, 2003, 17 (02) : 465 - 467

← 1 2 →